https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-02-24 / Oncol Lett 2016 Apr;11(4):2605-2610
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-02-24 / Oncol Lett 2016 Apr;11(4):2605-26102016-02-24 00:00:002019-02-15 08:45:42Dendritic cell vaccine and cytokine-induced killer cell therapy for the treatment of advanced non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-02-10 / Cancer Immunol. Immunother. 2016 Mar;65(3):327-39
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-02-10 / Cancer Immunol. Immunother. 2016 Mar;65(3):327-392016-02-10 00:00:002019-02-15 08:49:42Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-02-09 / Ther Adv Urol 2016 Jun;8(3):203-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-02-09 / Ther Adv Urol 2016 Jun;8(3):203-142016-02-09 00:00:002016-02-09 00:00:00Novel immunotherapeutic approaches to the treatment of urothelial carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-02-01 / Melanoma Res. 2016 Feb;26(1):1-11
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-02-01 / Melanoma Res. 2016 Feb;26(1):1-112016-02-01 00:00:002019-02-15 08:49:37Type I-polarized BRAF-pulsed dendritic cells induce antigen-specific CD8+ T cells that impact BRAF-mutant murine melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-01-22 / J. Exp. Clin. Cancer Res. 2016 Jan;35:18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-01-22 / J. Exp. Clin. Cancer Res. 2016 Jan;35:182016-01-22 00:00:002019-02-15 08:48:30Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-01-14 / Front Immunol 2015;6:663
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-01-14 / Front Immunol 2015;6:6632016-01-14 00:00:002021-11-15 13:26:00Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-01-07 / World J. Gastroenterol. 2016 Jan;22(1):253-61
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-01-07 / World J. Gastroenterol. 2016 Jan;22(1):253-612016-01-07 00:00:002019-02-15 08:47:51Current status and perspectives of immune-based therapies for hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-28 / Clin. Cancer Res. 2016 05;22(9):2155-66
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-28 / Clin. Cancer Res. 2016 05;22(9):2155-662015-12-28 00:00:002019-02-15 08:49:39Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-11 / Vaccines (Basel) 2015 Dec;3(4):1004-18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-11 / Vaccines (Basel) 2015 Dec;3(4):1004-182015-12-11 00:00:002019-02-15 08:39:04Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms‘ Tumor 1 in Patients with Advanced Colorectal Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-10 / Br. J. Cancer 2015 Dec;113(12):1666-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-10 / Br. J. Cancer 2015 Dec;113(12):1666-762015-12-10 00:00:002019-02-15 08:47:50A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
